Frank Rimerman Advisors LLC Has $2.18 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Frank Rimerman Advisors LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 52,000.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,773 shares of the company’s stock after purchasing an additional 6,760 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in HCA Healthcare were worth $2,176,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of HCA. Bangor Savings Bank increased its holdings in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares during the last quarter. MFA Wealth Advisors LLC purchased a new position in shares of HCA Healthcare in the second quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC grew its stake in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. purchased a new stake in shares of HCA Healthcare during the first quarter worth $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.3 %

Shares of HCA stock opened at $404.66 on Friday. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The business has a 50-day moving average of $370.57 and a 200 day moving average of $340.65. The stock has a market capitalization of $105.99 billion, a PE ratio of 20.17, a P/E/G ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $405.70.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same period in the prior year, the business posted $4.29 EPS. The firm’s revenue was up 10.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on HCA shares. Baird R W raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Royal Bank of Canada boosted their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Morgan Stanley initiated coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Robert W. Baird initiated coverage on HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price target on the stock. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock worth $6,407,273 over the last quarter. 1.60% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.